Cargando…
Decoding the evolutionary response to prostate cancer therapy by plasma genome sequencing
BACKGROUND: Investigating genome evolution in response to therapy is difficult in human tissue samples. To address this challenge, we develop an unbiased whole-genome plasma DNA sequencing approach that concurrently measures genomic copy number and exome mutations from archival cryostored plasma sam...
Autores principales: | Ramesh, Naveen, Sei, Emi, Tsai, Pei Ching, Bai, Shanshan, Zhao, Yuehui, Troncoso, Patricia, Corn, Paul G., Logothetis, Christopher, Zurita, Amado J., Navin, Nicholas E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7336456/ https://www.ncbi.nlm.nih.gov/pubmed/32631448 http://dx.doi.org/10.1186/s13059-020-02045-9 |
Ejemplares similares
-
The combination of serum insulin, osteopontin, and hepatocyte growth factor predicts time to castration-resistant progression in androgen dependent metastatic prostate cancer- an exploratory study
por: Dayyani, Farshid, et al.
Publicado: (2016) -
Large Extracellular Vesicle Characterization and Association with Circulating Tumor Cells in Metastatic Castrate Resistant Prostate Cancer
por: Gerdtsson, Anna S., et al.
Publicado: (2021) -
Response in bone turnover markers during therapy predicts overall survival in patients with metastatic prostate cancer: analysis of three clinical trials
por: Som, A, et al.
Publicado: (2012) -
Single-Trial Decoding of Bistable Perception Based on Sparse Nonnegative Tensor Decomposition
por: Wang, Zhisong, et al.
Publicado: (2008) -
Decoding the heterogeneous landscape in the development prostate cancer
por: Segura-Moreno, Yenifer Yamile, et al.
Publicado: (2021)